ArticleLeukemia2024

Genome-wide CRISPR/Cas9 library screening identified OGDH as a regulator of disease progress and resistance to decitabine in myelodysplastic neoplasm by reprogramming glutamine metabolism.

Xiaoyan Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.